The synthetic biology concept bottomed out and Ruifeng Hi-Tech rose by more than 15%. Previously, Blue Biotech went out of the 6-game market, with Yiqiao Shenzhou, Offshore Protein, Xinghu Technology, and Lukang Pharmaceutical leading the way in gains.
合成生物概念探底回升，瑞丰高材涨超15%，此前蔚蓝生物走出6连板，义翘神州、近岸蛋白、星湖科技、鲁抗医药等涨幅靠前。
The synthetic biology concept bottomed out and Ruifeng Hi-Tech rose by more than 15%. Previously, Blue Biotech went out of the 6-game market, with Yiqiao Shenzhou, Offshore Protein, Xinghu Technology, and Lukang Pharmaceutical leading the way in gains.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.